Fundraising Fox
PBS Biotech
Camarillo, US · Delaware corporation · 2 known investors
Find your way into PBS Biotech
Sign up to see every warm intro you have to PBS Biotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the PBS Biotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PBS Biotech develops Vertical-Wheel bioreactors and related accessories for scalable manufacturing of cell therapies, including allogeneic therapies derived from induced pluripotent stem cells, mesenchymal stem cells, and CAR-T or NK cells. It serves cell therapy developers from R&D through clinical trials and commercialization, offering products, consulting packages, and process scale-up support.
Founders & leadership
BL
Brian LeeFounder & Chief Technology OfficerBrian Lee is an executive officer and director at PBS Biotech with over 23 years of experience in biopharmaceutical R&D and biomanufacturing, including work on bioprocess development, scale-up, and technology transfer across cell culture, fermentation, and regenerative medicine platforms. He holds patents in biotech and biomanufacturing devices, has published in peer-reviewed journals, and serves on advisory boards for academic bioprocessing programs.
MC
Matt CroughanExecutive
NB
TM
BP
Bryan PoltiloveNamed on SEC filing
JL
Jung LimNamed on SEC filing
Board
Investors · 2
Reported raises · per SEC filings
Form D private placements$43.2M disclosed across 2 of 3 rounds · 2021–2024
▶$8.5MraisedSep 2024 · 3 investors · BiotechnologyRule 506(b)
▶$8.5MraisedSep 2024 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Xiaoshen LiaoDirector
- Brian LeeExecutive Officer, Director
- Daniel FriedmanDirector
- Matt CroughanExecutive Officer
- Nelson BermudezExecutive Officer
- Terrell MathewsExecutive Officer
- Dennis FentonDirector
- Leland FosterDirector
- Offering amount
- $17M
- Amount sold
- $8.5M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$34.7MraisedJan 2023 · 3 investors · BiotechnologyRule 506(b)
▶$34.7MraisedJan 2023 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bryan PoltiloveDirector
- Dennis FentonDirector
- Leland fosterDirector
- Jung LimDirector
- Brian LeeExecutive Officer, Director
- Xiaoshen (Jerry) LiaoDirector
- Offering amount
- $34.7M
- Amount sold
- $34.7M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does PBS Biotech do?
- PBS Biotech develops Vertical-Wheel bioreactors and related accessories for scalable manufacturing of cell therapies, including allogeneic therapies derived from induced pluripotent stem cells, mesenchymal stem cells, and CAR-T or NK cells. It serves cell therapy developers from R&D through clinical trials and commercialization, offering products, consulting packages, and process scale-up support.
- Who founded PBS Biotech?
- PBS Biotech was founded by Brian Lee.
- Who are PBS Biotech's investors?
- PBS Biotech's investors include Avego BioScience Capital, BroadOak Capital Partners.
- How much funding has PBS Biotech raised?
- PBS Biotech has disclosed $43.2M raised across 2 of its 3 known rounds.
- Where is PBS Biotech headquartered?
- PBS Biotech is headquartered in Camarillo, US.